Page 18 - Pfizer

To ease distribution US loosens Pfizer Covid vaccine shipping regulations

The Food and Drug Administration said Thursday that it's allowing the additional option after reviewing new data from New York-based Pfizer and its German partner, BioNTech

Pfizer-BioNTech testing booster of their Covid-19 vaccine in new trial

The companies believe their current two-dose vaccine will work against the South African variant as well as one found in the United Kingdom and elsewhere

Pfizer Covid-19 vaccine works well in big 'real world' test, prevents death

The vaccine was 92 percent effective at preventing severe disease after two shots and 62 percent after one

Brazil approves Pfizer's coronavirus vaccine, but has none to use

It is the first coronavirus shot to receive full approval in Brazil, regulator Anvisa said. Vaccines developed by AstraZeneca and China's Sinovac Biotech Ltd, have only been approved for emergency use

Pfizer-BioNTech vaccine stops Covid-19 spread by 90%, says study

This provides the first indication that the immunisation will curb transmission

Pfizer to double vaccine roll out as Biden assures shots for all by July

Pfizer CEO Albert Bourla said the company expects to double its rollout of coronavirus vaccines to 10 million a week over the next two weeks as Biden pledged enough supply of doses by July

Fresh Pfizer-BioNTech data shows coronavirus vaccine easier to use

Fresh Pfizer-BioNTech data shows coronavirus vaccine easier to use

Pfizer seeks US govt approval to ease handling of Covid-19 vaccine

Pfizer/BioNTech's vaccine, along with Moderna Inc's two-dose shot, won the US emergency use authorization (EUA) and is being widely distributed as part of the country's mass vaccination efforts

Pfizer submits data showing Covid vaccine's stability in refrigerators

If approved, this new storage option would offer pharmacies and vaccination centers greater flexibility in how they manage their vaccine supply

Pfizer's Covid-19 vaccine supply to the EU 30% below plans: Report

Only about 2 million of those doses due in December have been delivered

Covid-19: Pfizer vaccine gets final nod in Japan, to be rolled out soon

Japan, however, was still the last country among the Group of Seven nations to give it the OK as it required an additional clinical trial to be conducted on Japanese people to ensure safety

Japan health panel recommends approval of Pfizer coronavirus vaccine

Health Minister Norihisa Tamura says a formal approval is expected Sunday

US secures 200 million more doses of Moderna, Pfizer Covid-19 vaccines

The United States has secured an additional 200 doses of Moderna and Pfizer COVID-19 vaccines, President Joe Biden announced on Thursday (local time)."Just this afternoon, we signed the final contracts for 100 million more Moderna and 100 million more Pfizer vaccines. We're also able to move up the delivery dates with an additional 200 million vaccines to the end of July, faster than we expected and in further good news both companies agreed and we're now contractually obligated to expedite delivery of 100 million doses that were promised by the end of June to deliver them by the end of May," he said in an address to the National Institutes of Health.He also informed that the US is on track to have a vaccine supply for 300 million Americans by the end of July."Within three weeks, round the clockwork with so many people standing behind me and in front of me, we've now purchased enough vaccine supply to vaccinate all Americans, and now we're working to get those vaccines into the arms ..

Vaccine leadership, not chauvinism

The WHO's initiative to provide equitable access to vaccines - COVAX - is devoid of the funds needed to procure and supply the shots to poorer countries.

India's expert panel rejects Pfizer's application for Covid-19 vaccine

Cites serious adverse events

Pfizer retracts request for emergency approval of Covid-19 vaccine in India

Pfizer has not conducted any bridge trial on Indian population for its mRNA vaccine

Covid-19: Pfizer withdraws Emergency Use Authorisation application in India

Pfizer had a meeting with India's drugs regulator on Wednesday and the decision was made after that, the company said.

AstraZeneca and Pfizer Covid-19 vaccines to be combined in Oxford trial

The Astra and Pfizer vaccines will be given in different orders and with two dosing intervals, four and 12 weeks apart.

India to get around 97 million doses of AstraZeneca Covid-19 vaccine

As of now, Covax has not allotted the Pfizer-BioNTech vaccine for India.

India to get 97 million doses of Serum-made AstraZeneca vaccine from Covax

As of now, Covax has not disclosed the India distribution plan for the Pfizer-BioNTech vaccine